Niva Bupa share price target: A health insurance company, Niva Bupa, is a leading health insurance provider that allows customers to take a broader view of the health ecosystem through its app and website.
The company offers individuals, families, senior citizens, and many other customers access to a broader health insurance ecosystem.
Let’s explore key metrics!
Niva Bupa Share Price Target: Market Outlook
- Open Rs 93.15
- Previous Close Rs 92.70
- All-Time High Rs 109.34
- All-Time Low Rs 69.21
- Upper Circuit 111.24
- Lower Circuit 74.16
- 52-Week High Rs 109.34
- 52-Week Low Rs 69.21
- Volume 2,395,439
- V WAP 90.77
- Book Value 11.92 per share
- Face Value ₹ 10.0
- Market Cap ₹ 16,437 crore
Niva Bupa Share Price Target 2024 to 2030
| Niva Bupa Share Price Target Year | First Target | Second Target |
|---|---|---|
| 2024 | 80 | 100 |
| 2025 | 105 | 120 |
| 2026 | 130 | 140 |
| 2027 | 165 | 175 |
| 2028 | 215 | 225 |
| 2029 | 230 | 250 |
| 2030 | 270 | 300 |
Niva Bupa Share Price Target 2024
Target ₹ 80 – ₹100
Niva Bupa’s share price Target in 2024 is expected to be Rs 80 and could grow to Rs 100. To Know more about the key strengths and challenges that could affect Niva Bupa’s share price target. Here are three key facts.
Innovative Product:
Niva Bupa specialises in innovating and developing more efficient products that will contribute to the growth of customers. This product portfolio provides customers with smooth and diverse customer needs and helps to expand.
A unique and efficient product portfolio differentiates the company from peer insurance companies. The company offers various health insurance products to fulfill every individual’s needs.
Market Expansion:
Niva Bupa relies on new-age technology to create sustainable and advanced need-based products that cater to policyholders in tier-two and tier-three city and rural areas, positively affecting sales growth.
Niva Bupa Share Price Target 2025
Target ₹ 105 – ₹120
Niva Bupa’s share price target in 2025 is expected to be Rs105, while the higher target is Rs 120 driven by its growth potential. Here are key risks and challenges explained in detail, that could affect the share price target.
Regulatory Changes:
Niva Bupa’s business performance and policy premium collection show the company’s growth strength. Any changes in insurance regulation established by the Insurance Regulatory and Development Authority of India (IRDA) would influence Niva Bupa’s business performance and increase policy collection.
Managing these dynamics and offering comprehensive and competitive products to the targeted customer will be the key catalysts to incremental growth.
Market Competition:
In the competitive marketplace, companies like Reliance Health, ICICI Lombard, HDFC Health Insurance, and Star Health well-funded and established brands can pressure Niva Bupa’s market share, and affect revenue growth and the share price.
Also Read Zinka Logistics Share Price Target
Niva Bupa Share Price Target 2026
Target ₹ 320 – ₹360
Niva Bupa’s share price Target in 2026 is expected to be Rs 130 and could grow to Rs 140. Here are three key strengths and challenges that could affect Zinka Logistics’ share price target.
Niva Bupa Share Price Target 2030
Target ₹ 270 – ₹300
Niva Bupa’s share price Target in 2024 is expected to be Rs 270 and could grow to Rs 300. You would like to Know more about the key strengths and challenges that could affect Zinka Logistics’ share price target. Here are three key facts.
Intense Competition and Market Saturation:
Niva Bupa could face intense competition in the health Insurance sector in India, a highly competitive landscape with several well-established players like Reliance Health, ICICI Lombard, and HDFC Health Insurance companies competing for further growth and profit margins.
It is crucial to differentiate its product offering which could accelerate potential growth and increase market share.
Regulatory Risks and Compliance Challenges:
The changes in the laws and regulation norms established by the Insurance Regulatory and Development Authority of India (IRDA) could positively or negatively impact Niva Bupas’ business operations and growth trajectory.
Niva Bupa Shareholding Report
Shareholding of Niva Bupa
- Retail Investors 25.83%
- Promoter 55.98%
- Domestic Institutional Investors 3.56%
- Mutual Fund 6.01%
- FII 8.63%
Niva Bupa Financial Analysis
According to quarterly results, Niva Bupa announced that Q2 FY24 revenue from operations increased from Rs 992 crore in Q2 FY23 to Rs 1,360 crore in Q2 FY24. This is a significant turnaround from a net loss of Rs 8 crore in the corresponding quarter of the previous year to Rs 13 crore in Q2 FY24, reflecting strong growth.
Niva Bupa Business Model
Peers Competitors
| Companies | CMP | Market Cap |
| Star Health | 493 | 28,975 crore |
| ICICI Lumbard | 1898 | 93,980 crore |
| Go Digit | 331 | 30,383 crore |